Table.

Laboratory Data on Admission.

<Peripheral blood>		LDH	235 U/L	<Urinalysis>
WBC	6,200 /μL	CK	50 U/L	protein	30 mg/dL
Seg	83 %	BUN	15.9 mg/dL	glucose	(-)
Eosi	1 %	Cre	0.55 mg/dL	ketone body	(-)
Baso	0 %	Na	141 mEq/L	occult blood	(-)
Mono	7 %	K	5.0 mEq/L	urobilinogen	(2+)
Lymp	9 %	Cl	106 mEq/L	nitrate	(-)
RBC	260×104/μL	Ca	8.0 mg/dL	<Urinary sediment>
Hb	7.5 g/dL	<Serological tests>		red blood cell	1-5 /HPF
Hct	23.6 %	CRP	21.3 mg/dL	white blood cell	<1 /HPF
MCV	89.8 fL	KL-6	145 pg/mL	epithelial cell	(-)
MCH	28.8 pg	PCT	0.11 ng/mL	cast	1-10 /WF
MCHC	31.6 %	IgG	1,838 mg/dL	Bacteria	(-)
PLT	48.4×104/μL	IgA	422 mg/dL	<Bacteria test>
ESR	119 mm/h	IgM	54 mg/dL	Blood culture	(-)
<Coagulation>		IgG4	20.4 mg/dL	Urine culture	(-)
PT-INR	1.30	sIL-2R	759 U/mL
APTT	30 s	CEA	1.0 ng/mL
Fibrinogen	935 mg/dL	CA19-9	2.4 U/mL
FDP	13 μg/mL	CA125	13.9 U/mL
D-Dimer	0.8 μg/mL	ANA	(-)
<Blood chemistry>		MPO-ANCA	<1.0
Total protein	7.5 g/dL	PR3-ANCA	<1.0
Albumin	2.5 g/dL	β-D-glucan	<0.5 ng/mL
AST	33 U/L	Aspergillus Ab	(-)
ALT	20 U/L	IGRAs	(-)
ALP	355 U/L

WBC: white blood cells, RBC: red blood cells, Hb: hemoglobin, Hct: hematocrit, MCV: mean corpuscular volume, MCH: mean corpuscular hemoglobin, MCHC: mean corpuscular hemoglobin concentration, PLT: platelet, ESR: erythrocyte sedimentation rate, PT-INR: prothrombin time-international normalized ratio, APTT: activated partial thromboplastin, FDP: fibrin/fibrinogen degradation products, AST: aspartate aminotransferase, ALT: alanine aminotransferase, ALP: alkaline phosphatase, LDH: lactate dehydrogenase, CK: creatine kinase, BUN: blood urea nitrogen, Cre: creatinine, CRP: C-reactive protein, KL-6: Krebs von den Lungen-6, PCT: procalcitonin, Ig: immunoglobulin, sIL-2R: soluble interleukin-2 receptor, CEA: carcinoembryonic antigen, CA19-9: carbohydrate antigen 19-9, CA125: carbohydrate antigen 125, ANA: anti-nuclear antibody, MPO-ANCA: myeroperoxidase antineutrophil cytoplasmic antibody, PR3-ANCA: proteinase3 antineutrophil cytoplasmic antibody, IGRAs: interferon-gamma release assays